From PureTech Health PLC
PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercialising highly differentiated medicines for devastating diseases, including intractable cancers, lymphatic and gastrointestinal diseases, central nervous system disorders and inflammatory and immunological diseases, among others. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders. This pipeline, which is being advanced both internally and through PureTech’s Founded Entities, is comprised of 24 products and product candidates, including two that have been cleared by the US Food and Drug Administration (FDA). All of the underlying programmes and platforms that resulted in this pipeline of product candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on the Company’s unique insights into the biology of the brain, immune and gut, or BIG, systems and the interface between those systems, referred to as the BIG Axis. For more information, visit or connect with us on Twitter @puretechh.
6 Tide St Ste 400, Boston, 02210-2412, United States Map
Industry classification What's this?
FTSE industry
Health Care
FTSE supersector
Health Care
Company Level FCA Listing Category
Issuer Market Cap £m
Admission date
19 June 2015
Country of Incorporation

Twitter feed

From PureTech Health PLC
Is this your company? Log in to tell your story.